Regenerating islet-derived protein 3-α is a prognostic biomarker for gastrointestinal chronic graft-versus-host disease.
Regenerating islet-derived protein 3-α is a prognostic biomarker for gastrointestinal chronic graft-versus-host disease.
复制标题
DOI:
10.1182/bloodadvances.2021005420
复制
发表时间:
2022-05-24
期刊:
影响因子:
7.5
通讯作者:
Paczesny, Sophie
中科院分区:
文献类型:
--
作者:
DePriest, Brittany Paige;Li, Hong;Bidgoli, Alan;Onstad, Lynn;Couriel, Daniel;Lee, Stephanie J.;Paczesny, Sophie
Plasma levels of Reg3α were significantly increased in patients with GI-cGVHD compared with those without GI-cGVHD in 2 independent cohorts. Reg3α is a prognostic biomarker that identifies the likelihood of NRM in patients with GI-cGVHD. Prognostic biomarkers used to identify likelihood of disease progression have not been identified for chronic graft-versus-host disease (cGVHD), the leading cause of late nonrelapse mortality (NRM) in survivors of allogeneic hematopoietic cell transplantation. Gastrointestinal cGVHD (GI-cGVHD) has been particularly challenging to classify. Here, we analyzed 3 proteomics markers (Regenerating islet-derived protein 3-α [Reg3α], C-X-C motif ligand 9 [CXCL9], and Stimulation-2 [ST2]) in 2 independent cohorts of patients with cGVHD totaling 289 patients. Plasma concentrations of Reg3α were significantly increased in patients with GI-cGVHD (P = .0012) compared with those without (P = .01), but plasma concentrations of CXCL9 and ST2 were not. Patients with high Reg3α (≥72 ng/mL) vs low Reg3α had higher NRM (23% vs 11%; P = .015). Because Reg3α has been identified as a lower GI tract marker in acute GVHD, we correlated Reg3α with lower acute-like GI-cGVHD vs classical fibrotic-like esophageal manifestations and found that Reg3α did not differ between the subtypes. No difference was observed between upper GI tract and lower GI tract subtypes. Patients with extremely high Reg3α (≥180 ng/mL) had higher GI scores but not higher scores for the lower GI tract. In a multivariable Cox regression model, patients with high Reg3α were 1.9 times more likely to die without relapse. Our findings demonstrate the utility of Reg3α as a prognostic marker for GI-cGVHD. These data warrant prospective biomarker validation studies.
登录
查看更多内容
影响因子:
3.2
作者:
Pidala J;Kitko C;Lee SJ;Carpenter P;Cuvelier GDE;Holtan S;Flowers ME;Cutler C;Jagasia M;Gooley T;Palmer J;Randolph T;Levine JE;Ayuk F;Dignan F;Schoemans H;Tkaczyk E;Farhadfar N;Lawitschka A;Schultz KR;Martin PJ;Sarantopoulos S;Inamoto Y;Socie G;Wolff D;Blazar B;Greinix H;Paczesny S;Pavletic S;Hill G
通讯作者:
Hill G
影响因子:
32.4
作者:
Lai Y;Li D;Li C;Muehleisen B;Radek KA;Park HJ;Jiang Z;Li Z;Lei H;Quan Y;Zhang T;Wu Y;Kotol P;Morizane S;Hata TR;Iwatsuki K;Tang C;Gallo RL
通讯作者:
Gallo RL
影响因子:
3.2
作者:
Williams KM;Inamoto Y;Im A;Hamilton B;Koreth J;Arora M;Pusic I;Mays JW;Carpenter PA;Luznik L;Reddy P;Ritz J;Greinix H;Paczesny S;Blazar BR;Pidala J;Cutler C;Wolff D;Schultz KR;Pavletic SZ;Lee SJ;Martin PJ;Socie G;Sarantopoulos S
通讯作者:
Sarantopoulos S
影响因子:
6.5
作者:
Jiang, Ziwei;Liu, Yuanqi;Lai, Yuping
通讯作者:
Lai, Yuping
DOI:
10.1016/j.bbmt.2014.12.001
发表时间:
2015-03
期刊:
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
影响因子:
--
作者:
Jagasia MH;Greinix HT;Arora M;Williams KM;Wolff D;Cowen EW;Palmer J;Weisdorf D;Treister NS;Cheng GS;Kerr H;Stratton P;Duarte RF;McDonald GB;Inamoto Y;Vigorito A;Arai S;Datiles MB;Jacobsohn D;Heller T;Kitko CL;Mitchell SA;Martin PJ;Shulman H;Wu RS;Cutler CS;Vogelsang GB;Lee SJ;Pavletic SZ;Flowers ME
通讯作者:
Flowers ME